Extracorporeal Pulse Activation Technology (EPAT) is a non-invasive therapy option for acute and chronic pain. High-energy shockwaves are focused onto the affected area to stimulate the speed up of the body’s own healing process. EPAT can over-stimulate nerves which reduces sensitivity and pain in the area.
It is one of the most advanced and highly effective noninvasive therapy methods approved by the FDA for conditions that are treatable. The therapy works by helping to improve the regenerative potential, enhancing blood circulation to regenerate damaged tissue which can eliminate/reduce pain, accelerate healing, and restore mobility, thus improving patients’ quality of life. Beneficial effects are often experienced after only 1 or 2 treatments and there is little or no downtime.
Extracorporeal Pulse Activation Technique (EPAT) is approved in the US by the Food and Drug Administration (FDA) for treatment of plantar fasciitis and tennis elbow. There is an FDA study to treat recalcitrant diabetic wounds. The FDA approved Storz D-Actor 100 device to administer ESWT.
The UK advisory body, the National Institute for Health and Care Excellence (NICE), have issued guidance on ESWT to UK clinicians for a number of clinical indications including calcific tendinitis of the shoulder, refractory plantar fascitiis, refractory Achilles tendinopathy, refractory tennis elbow, and refractory greater trochanteric pain syndrome.
“I went to Noel Relief Centers after my back became so painful I could barely function. As the therapy program progressed, my neck and back became more pain-free and looser...I am very thankful that after many years of suffering that my condition has improved considerably.” - GeneRead More...